Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HIO Fund
United States
- Ownership
- Private
- Development stage
- Other
01
Overview
The requested name "HIO Fund" appears to correspond to Western Asset High Income Opportunity Fund, a publicly traded U.S. closed-end fixed income fund rather than a life sciences, biotech, pharma, or healthcare operating company. The fund invests primarily in high-yield corporate debt securities and seeks high current income, with capital appreciation as a secondary objective. It is managed within the Western Asset/Franklin Templeton platform and trades on the NYSE under the symbol HIO. Because it is an investment fund, it does not have a therapeutic pipeline, drug programs, targets, indications, or platform technology in the biotech sense.
- Industry
- Investors
Beyond the preview
Go deeper on HIO Fund.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on HIO Fund.